- Mirador unveils part of pipeline with drug from Kira to rival TavneosMirador Therapeutics, the secretive immune disease biotech with more than $650 million in VC funding, is finally revealing a piece of its pipeline. The San Diego biotech said Thursday it reached…Endpoints · 8d ago↗ source
- STAT+: Fresh turmoil roils American Diabetes Association following controversy at conferenceTurmoil at the ADA has taken a fresh turn, with leaders blocking editors at its flagship journal from publishing pieces detailing a controversy at the group’s annual meeting.STAT · 8d ago↗ source
- Predicting biotech clinical trials and a new Alzheimer’s drug controversyThis week on "The Readout LOUD" podcast: a new Alzheimer's drug controversy and prediction markets for clinical trials and FDA drug reviews. Listen now.